Works matching IS 17762596 AND DT 2022 AND VI 17 AND IP 4

Results: 10

Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.

Published in:

2022

By:

Dubois, Fatéméh;
Bazille, Céline;
Levallet, Jérôme;
Maille, Elodie;
Brosseau, Solenn;
Madelaine, Jeannick;
Bergot, Emmanuel;
Zalcman, Gérard;
Levallet, Guénaëlle

Publication type:

journal article

Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry.

Published in:

2022

By:

Verry, Camille;
Vincendeau, Sébastien;
Massetti, Marc;
Blachier, Martin;
Vimont, Alexandre;
Bazil, Marie-Laure;
Bernardini, Pauline;
Pettré, Ségolène;
Timsit, Marc-Olivier

Publication type:

journal article

Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.

Published in:

Targeted Oncology, 2022, v. 17, n. 4, p. 483, doi. 10.1007/s11523-022-00898-7

By:

Tan, Elaine S.;
Fan, Wenyi;
Knepper, Todd C.;
Schell, Michael J.;
Sahin, Ibrahim H.;
Fleming, Jason B.;
Xie, Hao

Publication type:

Article

What's Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma.

Published in:

Targeted Oncology, 2022, v. 17, n. 4, p. 383, doi. 10.1007/s11523-022-00897-8

By:

Costa, Bruno Almeida;
Mouhieddine, Tarek H.;
Richter, Joshua

Publication type:

Article

Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria.

Published in:

2022

By:

Nemoto, Yuki;
Ishihara, Hiroki;
Nakamura, Kazutaka;
Tachibana, Hidekazu;
Fukuda, Hironori;
Yoshida, Kazuhiko;
Kobayashi, Hirohito;
Iizuka, Junpei;
Shimmura, Hiroaki;
Hashimoto, Yasunobu;
Tanabe, Kazunari;
Kondo, Tsunenori;
Takagi, Toshio

Publication type:

journal article

Author's Reply to Şener and Begijanashvili: "Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy".

Published in:

2022

By:

Sheng, Iris Y.;
Khorana, Alok A.

Publication type:

Letter

Comment on: "Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy".

Published in:

2022

By:

Şener, Yusuf Ziya;
Begijanashvili, Salome

Publication type:

Letter

Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.

Published in:

Targeted Oncology, 2022, v. 17, n. 4, p. 433, doi. 10.1007/s11523-022-00893-y

By:

Girgis, Suzette;
Lin, Shun Xin Wang;
Pillarisetti, Kodandaram;
Banerjee, Arnob;
Stephenson, Tara;
Ma, Xuewen;
Shetty, Shoba;
Yang, Tong-Yuan;
Hilder, Brandi W.;
Jiao, Qun;
Hanna, Brett;
Adams III, Homer C;
Sun, Yu-Nien;
Sharma, Amarnath;
Smit, Jennifer;
Infante, Jeffrey R.;
Goldberg, Jenna D.;
Elsayed, Yusri

Publication type:

Article

Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study.

Published in:

Targeted Oncology, 2022, v. 17, n. 4, p. 467, doi. 10.1007/s11523-022-00892-z

By:

Maruzzo, Marco;
Pierantoni, Francesco;
Bortolami, Alberto;
Palleschi, Dario;
Zivi, Andrea;
Nicodemo, Maurizio;
Sartori, Donata;
De Vivo, Rocco;
Zustovich, Fable;
Bimbatti, Davide;
Pastorelli, Davide;
Vultaggio, Giuseppe Dione;
Soraru', Mariella;
Ballestrin, Melissa;
Modonesi, Caterina;
Randisi, Paola;
Barile, Carmen;
Perri, Gino;
Basso, Umberto;
Zagonel, Vittorina

Publication type:

Article

Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index.

Published in:

Targeted Oncology, 2022, v. 17, n. 4, p. 453, doi. 10.1007/s11523-022-00889-8

By:

Ortega-Franco, Ana;
Hodgson, Clare;
Raja, Haseem;
Carter, Mathew;
Lindsay, Colin;
Hughes, Sarah;
Cove-Smith, Laura;
Taylor, Paul;
Summers, Yvonne;
Blackhall, Fiona;
Califano, Raffaele

Publication type:

Article